Clinical trial
Toward Immune Biomarkers for Tolerance and GvHD in Humans
NCT02319226 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Toward Immune Biomarkers for Tolerance and GvHD in Humans
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- October 31, 2020
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone marrow transplantation, graft vs host disease, hematopoietic stem cell transplantation